BioSpace News Archive

Business

Cantel Medical Promotes Lawrence Conway to Senior Vice President, Business Systems and Integration

In this role, Mr. Conway will be responsible for the integration of Cantel’s acquisitions along with his current role of leading the business systems function.

February 14, 2018

·

2 min read

Pharm Country

Certara Launches Version 10 of D360, Its Industry-leading Drug Discovery Informatics Platform

Certara announced the launch of version 10 of D360™, its data informatics platform for discovery scientists.

February 14, 2018

·

2 min read

Biotech Bay

Simplify Medical Completes Enrollment in IDE Trial Studying Simplify Disc in One Level of Spine for Cervical Disc Replacement

Simplify Medical today announced completion of enrollment in its U.S. IDE trial studying the Simplify Disc used for one-level cervical implantation of the device between C3 to C7 compared with a historical control group.

February 14, 2018

·

3 min read

Drug Development

Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic Keratosis

Actinic keratosis is a common skin condition that is induced through ultra-violet light damage, resulting in patches of thick, scaly, or crusty skin.

February 14, 2018

·

6 min read

Genetown

Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Ra Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 8,400,000 shares of its common stock at a public offering price of $6.00 per share, before underwriting discounts.

February 14, 2018

·

3 min read

Drug Development

Sienna Biopharmaceuticals Announces First Patient Dosed in First-in-Human Trial of Topical SNA-125

The trial will evaluate the safety, tolerability and efficacy of SNA-125 compared to vehicle and other reference formulations in approximately 15 patients with chronic psoriasis.

February 14, 2018

·

4 min read

Drug Development

MyoKardia Begins Patient Dosing in Phase Ib Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients

MYK-491 is being developed in an ongoing collaboration between MyoKardia and Sanofi for the treatment of patients with dilated cardiomyopathy.

February 14, 2018

·

7 min read

Business

Shire plc: Final Results - Feb. 14, 2018

Shire reports 8% pro forma product sales and strong earnings growth resulting in record operating cash flow for full year 2017.

February 14, 2018

·

56 min read

Business

Agios Reports Fourth Quarter and Full Year 2017 Financial Results

In addition, Agios highlighted select 2018 corporate milestones and data presentations for its clinical development programs.

February 14, 2018

·

13 min read

Midatech Pharma Plc: Trading Update - Feb. 14, 2018

The company provided a trading update ahead of its full year results for the twelve months ended 31 December 2017.

February 14, 2018

·

5 min read